免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

cCeLL - 適用於體內

K 號:K233391 · 2024-08-21

決定日期2024-08-21
產品代碼GWG
諮詢委員會NE (請提供完整的英文描述,以便進行翻譯。)
決定相當於

器材摘要

cCeLL - In vivo is the device name listed in this FDA 510(k) record. The listed applicant is VPIX Medical, Inc.. It received FDA 510(k) clearance on 2024-08-21 under 510(k) number K233391. The device is classified under product code GWG. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the cCeLL - In vivo?

cCeLL - In vivo is a medical device that received FDA 510(k) clearance on 2024-08-21. The listed applicant is VPIX Medical, Inc.. The 510(k) number is K233391.

When did cCeLL - In vivo receive FDA 510(k) clearance?

cCeLL - In vivo received FDA 510(k) clearance on 2024-08-21, under 510(k) number K233391.

Who is the listed applicant for cCeLL - In vivo?

The FDA 510(k) record lists VPIX Medical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for cCeLL - In vivo?

The FDA product code for cCeLL - In vivo is GWG.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 VPIX Medical, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:GWG)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑